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Letter 
 
Bone marrow biopsy findings in brucellosis patients with hematologic abnormalities: 
useful remarks 
 
o the editor: We found very interesting the paper by Demir et 
al1 about bone marrow biopsy findings in brucellosis patients. 
Although brucellosis remains the world’s most common bacterial 
zoonosis, with over half a million new cases annually and 
prevalence rates in some countries exceeding ten cases per 100 000 
population and can result in serious clinical complications, 
scientific and public health interest and funding for these diseases 
remain relatively minor and inadequate.2 In the paper by Demir et 
al,1 forty-eight brucellosis cases were prospectively investigated. 
Anemia, leukopenia, thrombocytopenia and pancytopenia were 
found in 39 (81%), 28 (58%), 22 (46%) and 10 patients (21%), 
respectively. In addition, hemophagocytosis was observed in 15 
(31%) patients. The clinical characteristics of these 15 patients did 
not significantly differ from those of the other patients. As it is 
known, the identification of hemophagocytosis in marrow biopsy 
aspirate (BMA) represents one of the diagnostic criteria for the 
diagnosis of the hemophagocytic lymphohistiocytosis (HLH) 
syndrome developed by the HLH Study Group of the Histiocyte 
Society.3 HLH is a potentially fatal hyperinflammatory syndrome 
characterized by histiocyte proliferation and hemophagocytosis. 
HLH may be inherited (primary, familial, generally occurring in 
infants) or secondary to infection, malignancy or rheumatologic 
disease and occurring at any age. The diagnosis of HLH is 
established by fulfilling one of the following criteria: (1) A 
molecular diagnosis consistent with primary HLH (e.g. PRF 
mutations, SAP mutations, MUNC13-4 mutations); (2) Having five 
out of eight of the following: fever; splenomegaly; cytopenia 
(affecting more than two cell lineages, ≤9 g haemoglobin per dl, 
≤100 000 platelets per ml, ≤1000 neutrophils per ml); 
hypertriglyceridaemia (≥265 mg triglycerides per dl) and/or 
hypofibrinogenaemia (≤150 mg fibrinogen per dl); 
haemophagocytosis in the bone marrow, spleen, or lymph nodes 
without evidence of malignancy; low or absent natural killer (NK) 
cell cytotoxicity; hyperferritinaemia (≥500 ng ferritin per ml); 
elevated soluble CD25 (≥2400 IU interleukin-2Ra chain per ml).3 
Two points should be stressed: (1) the identification of 
hemophagocytosis in BMA represents only one of 5/8 criteria 
needed for the diagnosis of HLH; (2) a diagnosis of primary HLH 
should always be excluded. In fact, with improved molecular 
diagnostics it is recognized that cases of adult onset HLH that had 
previously been considered secondary may represent a primary 
HLH with underlying mutation in the PFR1 gene. 
 
In conclusion, we think that HLH should be considered in severe 
cases of brucellosis especially if associated with pancytopenia, and 
the finding of hemophagocytosis in BMA of patients with 
brucellosis is not necessarily associated with a severe disease. 
Further studies are needed to understand whether an 
immunosuppressive treatment could be beneficial in those cases 
that do not respond promptly to antibiotic therapy. 
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